IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95% Market Closed
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

Wall Street
Price Targets

IRLAB A Price Targets Summary
IRLAB Therapeutics AB

There are no price targets for IRLAB A.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
IRLAB Therapeutics AB Competitors:
Price Targets
GLAND
Gland Pharma Ltd
14% Upside
WEED
Canopy Growth Corp
25% Upside
EOLS
Evolus Inc
46% Upside
300363
Porton Pharma Solutions Ltd
32% Upside
AUROPHARMA
Aurobindo Pharma Ltd
15% Upside
ERIS
Eris Lifesciences Ltd
5% Upside

Revenue
Forecast

Revenue Estimate
IRLAB Therapeutics AB

For the last 7 years the compound annual growth rate for IRLAB Therapeutics AB's revenue is 69%. The projected CAGR for the next 3 years is 152%.

69%
Past Growth
152%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
IRLAB Therapeutics AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
IRLAB Therapeutics AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IRLAB A's stock price target?
Not Available

IRLAB A doesn't have any price targets made by Wall Street professionals.

What is IRLAB Therapeutics AB's Revenue forecast?
Projected CAGR
152%

For the last 7 years the compound annual growth rate for IRLAB Therapeutics AB's revenue is 69%. The projected CAGR for the next 3 years is 152%.

Back to Top